CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | COSTA SANTO J Director | Grant or award · Stock Option (Right to Purchase) | +38,000 | 38,000 | ||
| 2024-06-07 | Korczynski Sherry SVP Sales and Marketing | Grant or award | +25,000 | 25,000 | ||
| 2024-05-10 | Wargacki Stephen Chief Science Officer | Grant or award | +10,000 | 267,963 | ||
| 2024-05-10 | Jenkins Abigail L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | −57,000 | 57,000 | ||
| 2024-03-15 | Schobel Alexander Mark Chief Innovation/Tech Officer | Sale 10b5-1 | −50,000 | $6.00 | $300K | 984,476 |
| 2024-03-10 | Wargacki Stephen SVP, Research & Development | Shares withheld for taxes | −1,687 | $4.88 | $8K | 257,963 |
| 2024-03-10 | Jung Cassie SVP, Operations | Shares withheld for taxes | −1,132 | $4.88 | $6K | 237,754 |
| 2024-03-09 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes | −9,645 | $4.88 | $47K | 980,726 |
| 2024-03-09 | Wargacki Stephen Chief Science Officer | Shares withheld for taxes | −19,505 | $4.88 | $95K | 261,414 |
| 2024-03-09 | Barber Daniel President and CEO | Shares withheld for taxes | −56,824 | $4.88 | $277K | 826,478 |
| 2024-03-09 | Jung Cassie SVP, Operations | Shares withheld for taxes | −14,120 | $4.88 | $69K | 233,066 |
| 2024-03-09 | Barber Daniel President and CEO | Shares withheld for taxes | −37,938 | $4.88 | $185K | 845,364 |
| 2024-03-09 | Boyd Peter E. See Remark | Shares withheld for taxes | −8,370 | $4.88 | $41K | 237,628 |
| 2024-03-09 | BRAENDER LORI J SVP, General Counsel | Shares withheld for taxes | −10,530 | $4.88 | $51K | 313,231 |
| 2024-03-09 | TOTH A ERNEST JR SVP, Chief Financial Officer | Shares withheld for taxes | −11,705 | $4.88 | $57K | 248,295 |
| 2024-03-09 | Wargacki Stephen SVP, Research & Development | Shares withheld for taxes | −11,269 | $4.88 | $55K | 259,650 |
| 2024-03-09 | Jung Cassie SVP, Operations | Shares withheld for taxes | −8,300 | $4.88 | $41K | 238,886 |
| 2024-03-09 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes 10b5-1 | −5,895 | $4.88 | $29K | 1,034,476 |
| 2024-03-08 | Schobel Alexander Mark Chief Innovation/Tech Officer | Sale 10b5-1 | −25,000 | $5.19 | $130K | 1,040,371 |
| 2024-03-07 | BRAENDER LORI J SVP, General Counsel | Grant or award | +135,000 | 323,761 |
Page 8 of 24 · 462 trades